RE:RE:RE:RE:RE:RE:RE:Theralase has already won
Hey, reality sucks. Here we are at .24 cents. If TLT had anyting that looked good in terms of a cancer cure, the stock might be a lot higher. There is no speculation, no pharma, no institutional funding. The potential is still in the starting blocks with another 10,000 studies that are going on.